Impact of highly active antiretroviral therapy on the natural history of cervical precancerous lesions: A 17-year institutional longitudinal cohort study

Reproductive Sciences

Volumn 21, Issue 7, 2014, Pages 837-845

  Patrelli, Tito Silvio ^a   Gizzo, Salvatore ^b   Peri, Francesca ^a   Franchi, Laura ^a   Volpi, Lavinia ^a   Esposito, Federica ^b   Pedrazzi, Giuseppe ^a   Antoni, Anna Degli ^a   Modena, Alberto Bacchi ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

gynecological screening; HAART effect; HIV clinical stage; HIV pharmacological therapy; HIV related comorbidity; precancerous cervical lesions

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COLPOSCOPY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; NARCOTIC DEPENDENCE; OBSERVATIONAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROSTITUTION; SEXUAL PROMISCUITY; SEXUALLY TRANSMITTED DISEASE; SMOKING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS LOAD;

EID: 84904619962     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113512531     Document Type: Article

References (31)

1. IARC: Monographs on the Evalutation of carcinogenic risks to Humans Volume 90. Human Papillomaviruses Lyon: AIRC Press; 2007. http://monographs. iarc.fr/ENG/Monographs/vol90/mono90.pdf. Accessed May 2013.
2. Dal Maso L, Franceschi S, Lise M, et al. Screening of HIV-positive women in Emilia-Romagna (SHER) Study. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer. 2010 ; 10: 310
3. Dal Maso L, Polesel J, Serraino D, et al. Cancer and AIDS Registries Linkage (CARL) Study. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009 ; 100 (5). 840-847
4. Anastos K, Hoover DR, Burk RD, et al. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS One. 2010 ; 5 (10). e13525
5. Gizzo S, Ancona E, Patrelli TS, et al. Fertility preservation in young women with cervical cancer: an oncologic dilemma or a new conception of fertility sparing surgery?. Cancer Invest. 2013 ; 31 (3). 189
6. CliffordGMFranceschiS. Cancer risk in HIV-infected persons: influence of CD4(+) count. Future Oncol. 2009;5(5):669-678.
7. Mogtomo ML, Malieugoue LC, Djiepgang C, Wankam M, Moune A, Ngane AN. Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy. Infect Agent Cancer. 2009 ; 4: 9
8. Gonçalves MA, Soares EG, Donadi EA. The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity. Infect Agent Cancer. 2009 ; 4: 11
9. Società Italiana di Colposcopia e Patologia Cervico-Vaginale. Linee guida nella Gestione della Paziente con Pap Test Anormale; La colposcopia in Italia XII; 1, 2006. http://sigo.web-designer-roma.com/usr-files/linee-guida- sigo/LineeGuidaColposcopia06.pdf. Accessed May 2013.
10. Società Italiana di Colposcopia e Patologia Cervico-Vaginale. Linee guida nella Gestione della Paziente con Pap Test Anormale; 1, 2002.
11. JAMA. 1989 ; 262 (7). 931-934
12. Broder S. From the national institutes of health. JAMA. 1992 ; 267 (14). 1892
13. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002 ; 287 (16). 2114-2119
14. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000 ; 283 (8). 1031-1037
15. De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008 ; 17 (6). 545-554
16. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol. 2003 ; 15 (5). 382-388
17. Stern PL, Brown M, Stacey SN, et al. Natural HPV immunity and vaccination strategies. J Clin Virol. 2000 ; 19 (1-2). 57-66
18. Gage JR, Sandhu AK, Nihira M, et al. Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression. Obstet Gynecol. 2000 ; 96 (6). 879-885
19. Massad LS, Evans CT, Weber KM, et al. Changes in knowledge of cervical cancer prevention and human papillomavirus among women with human immunodeficiency virus. Obstet Gynecol. 2010 ; 116 (4). 941-947
20. Saccardi C, Gizzo S, Noventa M, et al. High-risk human papillomavirus DNA test: could it be useful in low-grade cervical lesion triage? five-year follow-up [published online June 6, 2013]. Reprod Sci. 2013 ;:
21. Soncini E, Zoncada A, Condemi V, Antoni AD, Bocchialini E, Soregotti P. Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy. Acta Biomed. 2007 ; 78 (1). 36-40
22. Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, Brown DR. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2009 ; 51 (3). 274-282
23. Sirera G, Videla S, López-Blázquez R, et al. Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3. J Antimicrob Chemother. 2008 ; 61 (1). 191-194
24. Heard I. Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS. 2009 ; 4 (1). 68-73
25. Paramsothy P, Jamieson DJ, Heilig CM, et al. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol. 2009 ; 113 (1). 26-31
26. Massad LS, Evans CT, Wilson TE, et al. Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. Gynecol Oncol. 2010 ; 117 (1). 70-76
27. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007 ; 99 (12). 962-972
28. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005 ; 97 (6). 425-432
29. Tsai HT, Tsai YM, Yang SF, et al. Lifetime cigarette smoke and second-hand smoke and cervical intraepithelial neoplasm - a community-based case-control study. Gynecol Oncol. 2007 ; 105 (1). 181-188
30. Minkoff H, Zhong Y, Burk RD, et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis. 2010 ; 201 (5). 681-690
31. Gizzo S, Noventa M, Nardelli GB. Gardasil administration to hr-HPV-positive women and their partners. Trends Pharmacol Sci. 2013 ; 34 (9). 479-480